BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Fuji
McKinsey
Citi
Teva
Colorcon
Chubb
Boehringer Ingelheim
Healthtrust
UBS

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,364,923

« Back to Dashboard

Summary for Patent: 4,364,923
Title: Chemical compounds
Abstract:An antiinflammatory steroid exhibiting a tendency to crystal growth in suspension in aerosol propellants is contacted with a halogenated hydrocarbon to form a crystalline solvate, which, after removal of some or all of the propellant from the crystals, is reduced to a particle size permitting inhalation into the human bronchial system when dispersed as an aerosol, the micronised crystalline solvate not thereafter exhibiting crystal growth in the aerosol propellant. The solvate is a new composition of matter which has been characterized by I.R. spectra and the aerosol formulation prepared therefrom has valuable therapeutic properties, particularly in the treatment of asthma.
Inventor(s): Cook; Peter B. (Standon, GB2), Hunt; John H. (Theydon Bois, GB2)
Assignee: Allen & Hanburs Limited (London, GB2)
Application Number:06/259,015
Patent Claim Types:
see list of patent claims
Formulation; Compound; Device;

Drugs Protected by US Patent 4,364,923

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,364,923

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom18421/72Apr 20, 1972

International Patents Family Members for US Patent 4,364,923

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 196524 ➤ Subscribe
Austria 348115 ➤ Subscribe
Austria 352973 ➤ Subscribe
Austria A302275 ➤ Subscribe
Austria A352973 ➤ Subscribe
Australia 471577 ➤ Subscribe
Australia 5466073 ➤ Subscribe
Belgium 798458 ➤ Subscribe
Canada 994753 ➤ Subscribe
Germany 2320111 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cipla
US Army
Johnson and Johnson
Express Scripts
Julphar
Baxter
Moodys
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot